Cargando…

Nasopharyngeal carcinoma incidence and mortality in China in 2009

Nasopharyngeal carcinoma (NPC) is rare globally but common in China and exhibits a distinct ethnic and geographic distribution. In 2009, the National Central Cancer Registry in China provided real-time surveillance information on NPC. Individual NPC cases were retrieved from the national database ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zhi-Jian, Zheng, Rong-Shou, Zhang, Si-Wei, Zou, Xiao-Nong, Chen, Wan-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sun Yat-sen University Cancer Center 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845582/
https://www.ncbi.nlm.nih.gov/pubmed/23863562
http://dx.doi.org/10.5732/cjc.013.10118
_version_ 1782293330131943424
author Xu, Zhi-Jian
Zheng, Rong-Shou
Zhang, Si-Wei
Zou, Xiao-Nong
Chen, Wan-Qing
author_facet Xu, Zhi-Jian
Zheng, Rong-Shou
Zhang, Si-Wei
Zou, Xiao-Nong
Chen, Wan-Qing
author_sort Xu, Zhi-Jian
collection PubMed
description Nasopharyngeal carcinoma (NPC) is rare globally but common in China and exhibits a distinct ethnic and geographic distribution. In 2009, the National Central Cancer Registry in China provided real-time surveillance information on NPC. Individual NPC cases were retrieved from the national database based on the ICD-10 topography code C11. The crude incidence and mortality of NPC were calculated by sex and location (urban/rural). China's population in 1982 and Segi's world population structures were used to determine age-standardized rates. In regions covered by the cancer registries in 2009, the crude incidence of NPC was 3.61/100,000 (5.08/100,000 in males and 2.10/100,000 in females; 4.19/100,000 in urban areas and 2.42/100,000 in rural areas). Age-standardized incidences by Chinese population (ASIC) and Segi's world population (ASIW) were 2.05/100,000 and 2.54/100,000, respectively. The crude mortality of NPC was 1.99/100,000 (2.82/100,000 in males and 1.14/100,000 in females; 2.30/100,000 in urban areas and 1.37/100,000 in rural areas). The age-standardized mortalities by Chinese population (ASMC) and world population (ASMW) were 1.04/100,000 and 1.35/100,000, respectively. The incidence and mortality of NPC were higher in males than in females and higher in urban areas than in rural areas. Both age-specific incidence and mortality were relatively low in persons younger than 30 years old, but these rates dramatically increased. Incidence peaked in the 60-64 age group and mortality peaked in the over 85 age group. Primary and secondary prevention, such as lifestyle changes and early detection, should be carried out in males and females older than 30 years of age.
format Online
Article
Text
id pubmed-3845582
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Sun Yat-sen University Cancer Center
record_format MEDLINE/PubMed
spelling pubmed-38455822013-12-11 Nasopharyngeal carcinoma incidence and mortality in China in 2009 Xu, Zhi-Jian Zheng, Rong-Shou Zhang, Si-Wei Zou, Xiao-Nong Chen, Wan-Qing Chin J Cancer Original Article Nasopharyngeal carcinoma (NPC) is rare globally but common in China and exhibits a distinct ethnic and geographic distribution. In 2009, the National Central Cancer Registry in China provided real-time surveillance information on NPC. Individual NPC cases were retrieved from the national database based on the ICD-10 topography code C11. The crude incidence and mortality of NPC were calculated by sex and location (urban/rural). China's population in 1982 and Segi's world population structures were used to determine age-standardized rates. In regions covered by the cancer registries in 2009, the crude incidence of NPC was 3.61/100,000 (5.08/100,000 in males and 2.10/100,000 in females; 4.19/100,000 in urban areas and 2.42/100,000 in rural areas). Age-standardized incidences by Chinese population (ASIC) and Segi's world population (ASIW) were 2.05/100,000 and 2.54/100,000, respectively. The crude mortality of NPC was 1.99/100,000 (2.82/100,000 in males and 1.14/100,000 in females; 2.30/100,000 in urban areas and 1.37/100,000 in rural areas). The age-standardized mortalities by Chinese population (ASMC) and world population (ASMW) were 1.04/100,000 and 1.35/100,000, respectively. The incidence and mortality of NPC were higher in males than in females and higher in urban areas than in rural areas. Both age-specific incidence and mortality were relatively low in persons younger than 30 years old, but these rates dramatically increased. Incidence peaked in the 60-64 age group and mortality peaked in the over 85 age group. Primary and secondary prevention, such as lifestyle changes and early detection, should be carried out in males and females older than 30 years of age. Sun Yat-sen University Cancer Center 2013-08 /pmc/articles/PMC3845582/ /pubmed/23863562 http://dx.doi.org/10.5732/cjc.013.10118 Text en Chinese Journal of Cancer http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License, which allows readers to alter, transform, or build upon the article and then distribute the resulting work under the same or similar license to this one. The work must be attributed back to the original author and commercial use is not permitted without specific permission.
spellingShingle Original Article
Xu, Zhi-Jian
Zheng, Rong-Shou
Zhang, Si-Wei
Zou, Xiao-Nong
Chen, Wan-Qing
Nasopharyngeal carcinoma incidence and mortality in China in 2009
title Nasopharyngeal carcinoma incidence and mortality in China in 2009
title_full Nasopharyngeal carcinoma incidence and mortality in China in 2009
title_fullStr Nasopharyngeal carcinoma incidence and mortality in China in 2009
title_full_unstemmed Nasopharyngeal carcinoma incidence and mortality in China in 2009
title_short Nasopharyngeal carcinoma incidence and mortality in China in 2009
title_sort nasopharyngeal carcinoma incidence and mortality in china in 2009
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845582/
https://www.ncbi.nlm.nih.gov/pubmed/23863562
http://dx.doi.org/10.5732/cjc.013.10118
work_keys_str_mv AT xuzhijian nasopharyngealcarcinomaincidenceandmortalityinchinain2009
AT zhengrongshou nasopharyngealcarcinomaincidenceandmortalityinchinain2009
AT zhangsiwei nasopharyngealcarcinomaincidenceandmortalityinchinain2009
AT zouxiaonong nasopharyngealcarcinomaincidenceandmortalityinchinain2009
AT chenwanqing nasopharyngealcarcinomaincidenceandmortalityinchinain2009